Description
HAVRIX 1DOSE Hepatitis A Vaccine 720 A (GSK) – Single Dose
HAVRIX 1DOSE Hepatitis A Vaccine 720 A by GlaxoSmithKline (GSK) is a highly effective vaccine designed to provide active immunization against Hepatitis A virus infection. This single-dose vaccine is formulated to stimulate the body’s immune system to build protection against the Hepatitis A virus, which primarily affects the liver and can cause acute liver disease.
Ideal for individuals at risk of Hepatitis A exposure—such as travelers to endemic areas, healthcare workers, and those with chronic liver conditions—HAVRIX offers long-lasting immunity following vaccination. The vaccine is administered intramuscularly and is suitable for adults and children aged one year and above.
Key Features:
-
Single-dose vaccine providing active immunity against Hepatitis A virus
-
Contains 720 antigen units (EL.U) for robust immune response
-
Manufactured by GlaxoSmithKline (GSK), a trusted pharmaceutical company
-
Suitable for adults and children aged 1 year and older
-
Administered via intramuscular injection by healthcare professionals
-
Helps prevent acute Hepatitis A infection and related liver complications
Usage Instructions:
-
Administer a single 1ml dose intramuscularly as per medical guidelines
-
Follow-up doses may be recommended based on healthcare provider’s advice
-
Not suitable for individuals with known hypersensitivity to vaccine components
-
Store under recommended conditions to maintain vaccine potency
HAVRIX 1DOSE Hepatitis A Vaccine 720 A is an essential preventive measure against Hepatitis A, offering reliable protection for at-risk populations.
Reviews
There are no reviews yet.